Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research.
Company Details
Company type
Year founded
2012
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
Adeno Associate Virus vector technology and Gene Therapy applications.